Drug recall D-0299-2022

Class I Terminated reported Jan 5, 2022

Product

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Reason for recall

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Lots and codes

Lots: 2141001-1A, 2141002-1A, Exp. 01/2024

Recall details

Recalling firm
Gilead Sciences, Inc., Foster City, CA
Quantity
53,473 vials
Distribution
Nationwide in the USA
Type
Voluntary: Firm initiated
Recall initiated
December 3, 2021
Terminated
July 25, 2022

Related products